Literature DB >> 21484868

Tourette syndrome: evolving concepts.

Joseph Jankovic1, Roger Kurlan.   

Abstract

Tourette syndrome is a common childhood-onset neurobehavioral disorder characterized by multiple motor and phonic tics affecting boys more frequently than girls. Premonitory sensory urges prior to tic execution are common, and this phenomenon helps to distinguish tics from other hyperkinetic movement disorders. Tourette syndrome is commonly associated with attention deficit hyperactivity disorder, obsessive-compulsive disorder, learning difficulties, and impulse control disorder. The pathophysiology of this complex disorder is not well understood. Involvement of basal ganglia-related circuits and dopaminergic system has been suggested by various imaging and postmortem studies. Although it is considered a genetic disorder, possibly modified by environmental factors, an intense search has thus far failed to find causative genes. Symptomatic treatment of tics chiefly utilizes various alpha adrenergic agonists, antidopaminergic drugs, topiramate, botulinum toxin, and deep brain stimulation. Habit reversal therapy and other behavioral approaches may be a reasonable option for some cases. Improved understanding of Tourette syndrome should lead to better symptomatic and more effective pathogenesis-targeted therapies.
Copyright © 2011 Movement Disorder Society.

Entities:  

Mesh:

Year:  2011        PMID: 21484868     DOI: 10.1002/mds.23618

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  36 in total

1.  Association of Catechol-O-methyltransferase val/met polymorphism with cognitive function in Gilles de la Tourette syndrome patients.

Authors:  Weidong Ji; Ning Li; Kang Ju; Hong Zheng; Chuang Yang; Ping Xu; Silu Chen; Aiai Cao; Xue Chen; Lanting Guo
Journal:  Neurol Sci       Date:  2014-11-04       Impact factor: 3.307

Review 2.  The genetics of Tourette syndrome.

Authors:  Hao Deng; Kai Gao; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2012-03-13       Impact factor: 42.937

3.  Why so many deep brain stimulation targets in Tourette's syndrome? Toward a broadening of the definition of the syndrome.

Authors:  Mauro Porta; Christian Saleh; Edvin Zekaj; Carlotta Zanaboni Dina; Alberto R Bona; Domenico Servello
Journal:  J Neural Transm (Vienna)       Date:  2016-01-06       Impact factor: 3.575

4.  Successful pallidal deep brain stimulation in 15-year-old with Tourette syndrome: 2-year follow-up.

Authors:  João Massano; Cláudia Sousa; Tom Foltynie; Ludvic Zrinzo; Marwan Hariz; Rui Vaz
Journal:  J Neurol       Date:  2013-07-25       Impact factor: 4.849

5.  Progress in research on Tourette syndrome.

Authors:  Kevin J Black; Joseph Jankovic; Tamara Hershey; Kevin St P McNaught; Jonathan W Mink; John Walkup
Journal:  J Obsessive Compuls Relat Disord       Date:  2014-10-01       Impact factor: 1.677

Review 6.  Systematic review of severity scales and screening instruments for tics: Critique and recommendations.

Authors:  Davide Martino; Tamara M Pringsheim; Andrea E Cavanna; Carlo Colosimo; Andreas Hartmann; James F Leckman; Sheng Luo; Alexander Munchau; Christopher G Goetz; Glenn T Stebbins; Pablo Martinez-Martin
Journal:  Mov Disord       Date:  2017-01-10       Impact factor: 10.338

7.  Pediatric movement disorders: Five new things.

Authors:  Joanna S Blackburn; Jonathan W Mink; Erika F Augustine
Journal:  Neurol Clin Pract       Date:  2012-12

8.  Histidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and mice.

Authors:  Kyle A Williams; Jean-Dominique Gallezot; Vladimir Pogorelov; Lissandra Castellan Baldan; Maximiliano Rapanelli; Michael Crowley; George M Anderson; Erin Loring; Roxanne Gorczyca; Eileen Billingslea; Suzanne Wasylink; Kaitlyn E Panza; A Gulhan Ercan-Sencicek; Kuakarun Krusong; Bennett L Leventhal; Hiroshi Ohtsu; Michael H Bloch; Zoë A Hughes; John H Krystal; Linda Mayes; Ivan de Araujo; Yu-Shin Ding; Matthew W State; Christopher Pittenger
Journal:  Neuron       Date:  2014-01-08       Impact factor: 17.173

9.  Treatment of Tourette syndrome.

Authors:  Roger M Kurlan
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

Review 10.  Immune-mediated animal models of Tourette syndrome.

Authors:  Mady Hornig; W Ian Lipkin
Journal:  Neurosci Biobehav Rev       Date:  2013-01-10       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.